Inovio Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $100 | $0 | $102 |
Gross Profit | -727 | -759 | -72 | |
EBITDA | -24,399 | -31,408 | -29,532 | -24,546 |
EBIT | -25,165 | -32,237 | -30,292 | -24,721 |
Net Income | -25,165,478 | -32,237 | -30,469 | -25,003 |
Net Change In Cash | 0 | 100 | 0 | 102 |
Free Cash Flow | -84,355,186 | -28,661 | -28,795 | -25,954 |
Cash | 21,687,480 | 34,392 | 19,601 | 14,310 |
Basic Shares | 28,140 | 27,197 | 23,291 | 22,793 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $832 | $10,262 | $1,774 | $7,411 |
Gross Profit | -2,671 | 4,766 | -2,956 | -86,834 |
EBITDA | -130,391 | -270,902 | -296,557 | -149,560 |
EBIT | -133,894 | -276,398 | -301,287 | -154,187 |
Net Income | -135,117 | -287,664 | -305,384 | -215,086 |
Net Change In Cash | 832 | 10,262 | 1,774 | 7,411 |
Cost of Revenue | -24,788 | -179,554 | 228,504 | |
Free Cash Flow | -124,686 | -217,184 | -216,939 | -179,499 |
Cash | 14,310 | 46,329 | 71,143 | 250,728 |
Basic Shares | 22,173 | 19,885 | 17,402 | 12,927 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.89 |
2024-06-30 | -$1.19 |
2024-03-31 | -$1.31 |
2023-12-31 | -$1.12 |
